Accelrys, an R&D software and services company has extended its partnership with Scynexis to market and sell the Scynexis Hit Explorer Operating System (HEOS) for drug discovery information management.
The HEOS system is a Software-as-a-Service (SaaS) workspace that supports real-time data sharing across multiple organizations engaged in collaborative drug discovery.
The agreement provides a Cloud-based system that accelerates and streamlines collaborative drug discovery for virtual teams.
In addition, HEOS provides organizations with secure, real-time access to chemical registration, biological assay results, computational and visual analytics, safety assessment and pharmacokinetics data in the Cloud.
No comments:
Post a Comment